Current and future perspective of registry utilisation for regulatory settings in Japan: pharmaceuticals, medical devices, and regenerative medicine products
Considerable attention has been paid to the utilisation of real-world data throughout the lifecycle of pharmaceuticals, medical devices, and regenerative products. In Japan, regulatory initiatives have been implemented to promote the utilisation of real-world data and evidence for regulatory decisio...
Saved in:
Main Authors: | Chieko Ishiguro, Yasutomo Teshima, Harumasa Nakamura |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Journal of Pharmaceutical Policy and Practice |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/20523211.2025.2523935 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-World Evidence and Managed Entry Agreements
by: Silvia Adami, et al.
Published: (2025-07-01) -
Real-world data: general regulatory approaches in the EU and Japan
by: M. A. Borzova
Published: (2022-01-01) -
DARWIN EU® is an electronic platform for the collection and analysis of health data in the European Union
by: K. S. Radaeva, et al.
Published: (2023-01-01) -
Educational pharmacoepidemiology and "Real-World Knowledge"
by: R. A. Bontsevich
Published: (2025-01-01) -
Maintaining patient registries, on the basis of which regulatory authorities can make decisions regarding medicines
by: A. V. Ivanov, et al.
Published: (2023-03-01)